Synoptics Group acquired by Scientific Digital Imaging Ensuring Synoptics will
Retain its Leading Position in Life Science Imaging
March 19th 2008 Cambridge, UK: Synoptics, a
world leader in the development and manufacture of innovative digital imaging
systems for life science applications, is pleased to announce it has been
acquired by newly formed UK imaging company, Scientific Digital Imaging (SDI).
The acquisition will provide Synoptics with both the investment and business
acumen to develop its portfolio of revolutionary products.
With SDI’s expert management team, the Synoptics Group comprising three
divisions: Syngene, Synbiosis and Syncroscopy will have the investment and
strategic guidance to continue offering a product range that embraces the
industry’s leading life science imaging technology.
Synoptics provides systems that life scientists need to improve the quality
and speed of their research and it is this customer focus which has driven the
success of the business in the past decade. Syngene, the largest division,
produces state-of-the-art equipment and software that are used to analyse 1-D
and 2-D gels of DNA or proteins stained with a vast array of dyes. Synbiosis
and Syncroscopy have expertise in providing solutions for automated microbial
colony counting and for automated microscopy imaging applications
respectively.
Jeremy Gibbs, SDI’s interim non-executive Chairman stated: “SDI’s growth is
based on a combination of business development and acquiring companies whose
people, products and services are a natural fit for us. The Synoptics Group of
companies is exactly of that type and therefore has massive potential to
thrive as part of SDI.”
Paul Ellwood, Synoptics’ newly appointed joint Managing Director added: “The
acquisition of Synoptics by SDI is a very positive move. It signals a new
phase of financial and management investment and means we can go from strength
to strength in providing the excellent products, as well as the professional
approach to customer service and delivery for which the Syngene, Synbiosis and
Syncroscopy divisions within the Synoptics Group have become world renowned.”
-Ends-
For Further Information Contact:
Jayne Arthur, Synoptics Ltd, Beacon House, Nuffield Road, Cambridge, CB4 1TF,
UK.
Tel: +44(0) 1223-727100 Fax +44 (0) 1223-727101
Email: jayne.arthur@synoptics.co.uk
Web site: www.synoptics.co.uk
Editor Contact:
Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax: + 44(0) 1462- 635327 Email:
sue6.pearson@ntlworld.com
Note to Editors
About Synoptics
Synoptics, based in Cambridge, UK is a world-leader in the development and
manufacture of innovative digital imaging systems for a range of scientific
applications. The Company has three divisions, Syngene, Syncroscopy and
Synbiosis of which Syngene is the largest.
Syngene produces advanced systems for molecular biologists and protein
chemists to analyse and document information from gels. Syncroscopy and
Synbiosis specialise in digital imaging solutions for microscopy and microbial
applications respectively. The Company, founded in 1985, currently employs 40
people in its UK and subsidiary operation in Frederick, USA.
About Scientific Digital Imaging
Scientific Digital Imaging (SDI), formed in 2007 is a company that focuses on
providing products and services for life science imaging and includes the
Synoptics Group.
Based in Cambridge, UK, SDI is funded by private equity and venture capital.
The Company is backed by an expert management team, which is a balance of
skilled engineers and experienced executives. The management team is
complemented by non-executive directors with expertise in growing and
directing hi-tech companies.
